Form 4: SYSCO CFO Receives Significant Equity Awards
Insider Transaction Report
SYSCO's EVP and CFO, Kenny K Cheung, was granted restricted stock units and stock options as part of the company's incentive plan.
Summary
- Kenny K Cheung, Executive Vice President and Chief Financial Officer of SYSCO CORP, reported changes in his beneficial ownership of company securities.
- On August 21, 2025, Mr. Cheung was granted 15,108 restricted stock units (RSUs) by the Compensation and Leadership Development Committee under the 2018 Omnibus Incentive Plan.
- These RSUs are scheduled to vest in three equal installments on August 21, 2025, August 21, 2026, and August 21, 2027.
- Also on August 21, 2025, Mr. Cheung received a grant of 40,198 stock options with an exercise price of $80.98.
- These stock options will vest and become exercisable in three equal installments on August 21, 2026, August 21, 2027, and August 21, 2028, and are set to expire on August 20, 2035.
- On August 22, 2025, 1,530 shares of common stock were disposed of at a price of $80.98 per share to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, Mr. Cheung directly beneficially owns 46,967.257 shares of common stock and 40,198 stock options.
Sentiment
Score: 7
Explanation: The filing reports routine executive compensation grants and tax-related share dispositions. While the grants are positive for aligning executive interests with shareholders, the overall impact on the company's fundamental outlook is neutral as it represents standard practice.
Positives
- The grant of 15,108 restricted stock units and 40,198 stock options to the EVP and CFO aligns executive incentives with long-term shareholder value.
- These equity awards are part of the company's 2018 Omnibus Incentive Plan, indicating a structured and approved approach to executive compensation.
Negatives
- The disposition of 1,530 shares of common stock at $80.98 to cover tax withholding obligations reduces the immediate direct beneficial ownership of common stock, though this is a standard and expected practice for equity compensation.
Future Outlook
Restricted stock units will vest in equal installments on August 21, 2025, August 21, 2026, and August 21, 2027. Stock options will vest and become exercisable in equal installments on August 21, 2026, August 21, 2027, and August 21, 2028, and will expire on August 20, 2035.
Industry Context
The grant of equity awards to a key executive like the CFO is a standard practice in publicly traded companies across various industries. It is a common mechanism for executive compensation designed to align management's long-term interests with those of shareholders.
Comparison to Industry Standards
- The structure of equity grants, including restricted stock units and stock options with multi-year vesting schedules, is consistent with typical executive compensation packages observed in large-cap companies within the food distribution and broader consumer staples sectors, such as US Foods Holding Corp. (USFD) or Performance Food Group Company (PFGC).
- The use of a pre-approved Omnibus Incentive Plan (2018 Omnibus Incentive Plan) for these grants reflects sound corporate governance practices, similar to those employed by industry peers to ensure transparency and shareholder approval for executive compensation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation Grant | The Compensation and Leadership Development Committee of the Board of Directors granted restricted stock units and stock options to the EVP and CFO. | 08/21/2025 | Reinforces executive alignment with shareholder interests through the company's established 2018 Omnibus Incentive Plan. |
Stakeholder Impact
- Shareholders: The equity grants align the interests of a key executive with long-term shareholder value, potentially encouraging performance that benefits the stock price.
- Employees (Executive): The EVP and CFO receives significant equity compensation, incentivizing continued commitment and performance.
Next Steps
- Continued vesting of the granted restricted stock units on August 21, 2026, and August 21, 2027.
- Continued vesting and exercisability of the granted stock options on August 21, 2026, August 21, 2027, and August 21, 2028.
Key Dates
| Date | Description |
|---|---|
| 08/21/2025 | Date of grant for 15,108 restricted stock units and 40,198 stock options. Also, the first vesting date for one-third of the restricted stock units. |
| 08/22/2025 | Date of disposition of 1,530 shares for tax withholding. |
| 08/25/2025 | Signature date of the reporting person's attorney-in-fact on the filing. |
| 08/21/2026 | Second vesting date for one-third of the restricted stock units and first vesting/exercisable date for one-third of the stock options. |
| 08/21/2027 | Third vesting date for one-third of the restricted stock units and second vesting/exercisable date for one-third of the stock options. |
| 08/21/2028 | Third vesting/exercisable date for one-third of the stock options. |
| 08/20/2035 | Expiration date for the granted stock options. |
Recommendation
holdThis Form 4 filing reports routine executive compensation grants and tax-related share dispositions, which are standard practice and do not typically indicate a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. Investors should consider broader financial performance and market conditions.
Keywords
SYSCO, SYY, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Stock Options, Kenny K Cheung, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.